Form 8-K - Current report:
SEC Accession No. 0001213900-25-017652
Filing Date
2025-02-27
Accepted
2025-02-27 08:00:38
Documents
14
Period of Report
2025-02-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0232270-8k_avalon.htm   iXBRL 8-K 26502
2 REDEMPTION AND ABANDONMENT AGREEMENT, DATED FEBRUARY 26, 2025, BY AND AMONG AVAL ea023227001ex10-1_avalon.htm EX-10.1 71610
  Complete submission text file 0001213900-25-017652.txt   288426

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE albt-20250226.xsd EX-101.SCH 3039
4 XBRL LABEL FILE albt-20250226_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE albt-20250226_pre.xml EX-101.PRE 22375
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0232270-8k_avalon_htm.xml XML 3684
Mailing Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728
Business Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728 732-780-4400
Avalon GloboCare Corp. (Filer) CIK: 0001630212 (see all company filings)

EIN.: 471685128 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38728 | Film No.: 25673116
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)